| Advanced Training And Rehab | |
|
1229 Wentzville Pkwy, Suite 209, Wentzville, MO 63385-3552 | |
| (314) 453-9997 | |
| Not Available |
| Full Name | Advanced Training And Rehab |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 1229 Wentzville Pkwy, Wentzville, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023569084 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Provider Name | Sarah A Willis |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1104050715 PECOS PAC ID: 8224187943 Enrollment ID: I20090528000369 |
News Archive
Ghana's recent "rollout of the rotavirus vaccine and, to much acclaim, a new vaccine against pneumococcal infections, makes it the first country in sub-Saharan African to introduce two new vaccines at the same time," the Guardian reports.
The U.S. Food and Drug Administration today approved Dupixent (dupilumab) to treat adults with nasal polyps (growths on the inner lining of the sinuses) accompanied by chronic rhinosinusitis (prolonged inflammation of the sinuses and nasal cavity).
Oncolytics Biotech Inc. today announced that an abstract covering preclinical research with reovirus (REOLYSIN) is available on the European CanCer Organisation (ECCO). The research is scheduled to be presented at the 22nd EORTC-NCI-AACR symposium on Molecular Targets and Cancer Therapeutics being held in Berlin, Germany from November 16th - 19th 2010.
To admit or not to admit? That's the question being asked by many emergency department (ED) physicians and hospital administrators hundreds of times a day. Hospitals often place patients into observation who might otherwise be admitted, because intensity of service and medical necessity for these patients are not clearly defined or documented.
› Verified 4 days ago
| Provider Name | Patrick J Huck |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1265586424 PECOS PAC ID: 9234226630 Enrollment ID: I20120103000679 |
News Archive
Ghana's recent "rollout of the rotavirus vaccine and, to much acclaim, a new vaccine against pneumococcal infections, makes it the first country in sub-Saharan African to introduce two new vaccines at the same time," the Guardian reports.
The U.S. Food and Drug Administration today approved Dupixent (dupilumab) to treat adults with nasal polyps (growths on the inner lining of the sinuses) accompanied by chronic rhinosinusitis (prolonged inflammation of the sinuses and nasal cavity).
Oncolytics Biotech Inc. today announced that an abstract covering preclinical research with reovirus (REOLYSIN) is available on the European CanCer Organisation (ECCO). The research is scheduled to be presented at the 22nd EORTC-NCI-AACR symposium on Molecular Targets and Cancer Therapeutics being held in Berlin, Germany from November 16th - 19th 2010.
To admit or not to admit? That's the question being asked by many emergency department (ED) physicians and hospital administrators hundreds of times a day. Hospitals often place patients into observation who might otherwise be admitted, because intensity of service and medical necessity for these patients are not clearly defined or documented.
› Verified 4 days ago
| Provider Name | Anthony Wear |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1255685996 PECOS PAC ID: 2466604152 Enrollment ID: I20121203000369 |
News Archive
Ghana's recent "rollout of the rotavirus vaccine and, to much acclaim, a new vaccine against pneumococcal infections, makes it the first country in sub-Saharan African to introduce two new vaccines at the same time," the Guardian reports.
The U.S. Food and Drug Administration today approved Dupixent (dupilumab) to treat adults with nasal polyps (growths on the inner lining of the sinuses) accompanied by chronic rhinosinusitis (prolonged inflammation of the sinuses and nasal cavity).
Oncolytics Biotech Inc. today announced that an abstract covering preclinical research with reovirus (REOLYSIN) is available on the European CanCer Organisation (ECCO). The research is scheduled to be presented at the 22nd EORTC-NCI-AACR symposium on Molecular Targets and Cancer Therapeutics being held in Berlin, Germany from November 16th - 19th 2010.
To admit or not to admit? That's the question being asked by many emergency department (ED) physicians and hospital administrators hundreds of times a day. Hospitals often place patients into observation who might otherwise be admitted, because intensity of service and medical necessity for these patients are not clearly defined or documented.
› Verified 4 days ago
| Provider Name | Erika L Buck |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1720673494 PECOS PAC ID: 2668880055 Enrollment ID: I20210423001944 |
News Archive
Ghana's recent "rollout of the rotavirus vaccine and, to much acclaim, a new vaccine against pneumococcal infections, makes it the first country in sub-Saharan African to introduce two new vaccines at the same time," the Guardian reports.
The U.S. Food and Drug Administration today approved Dupixent (dupilumab) to treat adults with nasal polyps (growths on the inner lining of the sinuses) accompanied by chronic rhinosinusitis (prolonged inflammation of the sinuses and nasal cavity).
Oncolytics Biotech Inc. today announced that an abstract covering preclinical research with reovirus (REOLYSIN) is available on the European CanCer Organisation (ECCO). The research is scheduled to be presented at the 22nd EORTC-NCI-AACR symposium on Molecular Targets and Cancer Therapeutics being held in Berlin, Germany from November 16th - 19th 2010.
To admit or not to admit? That's the question being asked by many emergency department (ED) physicians and hospital administrators hundreds of times a day. Hospitals often place patients into observation who might otherwise be admitted, because intensity of service and medical necessity for these patients are not clearly defined or documented.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Advanced Training And Rehab 14515 North Outer 40 Rd, Suite 110, Chesterfield, MO 63017-5791 Ph: () - | Advanced Training And Rehab 1229 Wentzville Pkwy, Suite 209, Wentzville, MO 63385-3552 Ph: (314) 453-9997 |
News Archive
Ghana's recent "rollout of the rotavirus vaccine and, to much acclaim, a new vaccine against pneumococcal infections, makes it the first country in sub-Saharan African to introduce two new vaccines at the same time," the Guardian reports.
The U.S. Food and Drug Administration today approved Dupixent (dupilumab) to treat adults with nasal polyps (growths on the inner lining of the sinuses) accompanied by chronic rhinosinusitis (prolonged inflammation of the sinuses and nasal cavity).
Oncolytics Biotech Inc. today announced that an abstract covering preclinical research with reovirus (REOLYSIN) is available on the European CanCer Organisation (ECCO). The research is scheduled to be presented at the 22nd EORTC-NCI-AACR symposium on Molecular Targets and Cancer Therapeutics being held in Berlin, Germany from November 16th - 19th 2010.
To admit or not to admit? That's the question being asked by many emergency department (ED) physicians and hospital administrators hundreds of times a day. Hospitals often place patients into observation who might otherwise be admitted, because intensity of service and medical necessity for these patients are not clearly defined or documented.
› Verified 4 days ago
Nicholas Joseph Schwent, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1428 W Meyer Rd, Wentzville, MO 63385 Phone: 636-887-3660 | |
Ms. Carolyn M.b. Livergood, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1428 W Meyer Rd, Wentzville, MO 63385 Phone: 636-327-3333 Fax: 636-327-6383 | |
Jennifer Whelan, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1428 W Meyer Rd, Wentzville, MO 63385 Phone: 636-887-3660 | |
Dr. Shelby Reynoso, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 280 Interstate Dr, Wentzville, MO 63385 Phone: 636-327-3800 | |
Cynthia Alvino, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 332 Stable Ln, Wentzville, MO 63385 Phone: 636-332-4940 Fax: 636-332-4941 | |
Andrew D Cartmill, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1832 Wentzville Pkwy, Wentzville, MO 63385 Phone: 636-327-7110 Fax: 636-327-7135 |